Home
University of Bergen
KG Jebsen Center for Genome-Directed Cancertherapy

News archive for KG Jebsen Center for Genome-Directed Cancertherapy

The picture shows Professor Per Eystein Lønning being interviewed at ASCO
Findings regarding new origin of breast cancer presented at ASCO 2022 (07.06.2022)
In an interview with journalist Julie Kalveland from Dagens Medisin (04.06.2022) Professor Per Eystein Lønning shares the most important findings from a Norwegian-American collaboration study on BRCA1-methylation in breast and ovarian cancer. These findings were presented orally by Lønning at ASCO (03.06.2022).